A Breakthrough in Oncology
Cancer treatment is evolving rapidly with modern medical technologies. One of the most promising advancements is Next Generation Sequencing (NGS), which is giving a new lease on life to stage-4 cancer patients. By analyzing the patient's DNA and identifying specific gene mutations, doctors can now provide targeted treatments.
How NGS Works Differently
Unlike traditional chemotherapy that affects the entire body, NGS dives deep into the tumor's DNA. Dr. Shyam Agarwal from Sir Ganga Ram Hospital explains that this technique pinpoints the exact genetic code responsible for rapid cancer cell growth, allowing doctors to prescribe specific medications that attack only the cancer cells.
"NGS allows us to understand the tumor's DNA deeply and target it precisely, minimizing damage to healthy cells and extending the lives of late-stage patients." — Dr. Shyam Agarwal, Chairman, Medical Oncology, Sir Ganga Ram Hospital
A Lifeline for Stage-4 Patients
When conventional treatments fail in advanced stages, NGS acts as a beacon of hope. With over 50 new targeted drugs and immunotherapy options available, patients experience fewer side effects and a better quality of life compared to conventional therapies.
